Myomo Inc. (MYO) earnings

MYO earnings moved a median of -2.79% by the close. Quarterly and annual MYO reports and results, each read against the price at its own news timestamp. Back to the MYO overview →

29 measured MYO earnings events.

Where these MYO earnings landedvs 27 measured MYO earnings reactions
MYO earningsMiddle 50% · -8.48% to +6.97%Zero: 0.00%Median: -2.79%Median -2.79%-15.00%0+15.00%
Middle 50% of MYO earnings reactions-8.48% to +6.97%
Median reaction (to close)-2.79%
Measured reactions27
Point-in-time · zero look-ahead

Half of the 27 MYO earnings events with a measured close landed between -8.48% and +6.97%; 37% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q MYOMO, INC. For: Jun 30SEC filing · Form 10-Q+9.31%+28.43%
Myomo Reports Second Quarter 2026 Financial and Operating ResultsPress release+9.31%+28.43%
Myomo to Report Second Quarter 2026 Financial Results on August 5Press release-0.91%+6.55%
Form 10-Q MYOMO, INC. For: Mar 31SEC filing · Form 10-Q+1.24%-7.01%
Myomo Reports First Quarter 2026 Financial and Operating ResultsPress release+1.24%-7.01%
Myomo to Report First Quarter 2026 Financial Results on May 7Press release-1.18%-4.20%
Form 10-K/A MYOMO, INC. For: Dec 31SEC filing · Form 10-K+0.00%+7.45%
Form 10-K MYOMO, INC. For: Dec 31SEC filing · Form 10-K-1.47%-10.00%
Myomo to Report Fourth Quarter 2025 Financial Results on March 9Press release-2.60%-2.79%
Form 10-Q MYOMO, INC. For: Sep 30SEC filing · Form 10-Q-1.05%-10.53%
Myomo Reports Third Quarter 2025 Financial and Operating ResultsPress release-1.05%-10.53%
Myomo to Report Third Quarter 2025 Financial Results on November 10Press release-0.21%-1.89%
Form 10-Q MYOMO, INC. For: Jun 30SEC filing · Form 10-Q-1.89%—
Myomo Reports Second Quarter 2025 Financial and Operating ResultsPress release-1.89%—
Myomo to Report Second Quarter 2025 Financial Results on August 11Press release+0.25%+0.00%
Form 10-Q MYOMO, INC. For: Mar 31SEC filing · Form 10-Q-1.92%-19.23%
Myomo Reports First Quarter 2025 Financial and Operating ResultsPress release-1.92%-19.23%
Myomo to Report First Quarter 2025 Financial Results on May 7Press release-1.46%-1.25%
Form 10-K MYOMO, INC. For: Dec 31SEC filing · Form 10-K+1.08%+5.39%
Myomo to Report Fourth Quarter 2024 Financial Results on March 10Press release+4.19%+6.28%
Form 10-Q MYOMO, INC. For: Sep 30SEC filing · Form 10-Q+6.28%+16.74%
Form 10-Q MYOMO, INC. For: Jun 30SEC filing · Form 10-Q+0.13%-8.31%
Myomo Reports Second Quarter 2024 Financial ResultsPress release+0.13%-8.31%
Myomo Reports Preliminary Second Quarter 2024 Revenues and Operating MetricsPress release+10.45%+30.87%
Form 10-Q MYOMO, INC. For: Mar 31SEC filing · Form 10-Q-2.06%-8.48%
Myomo Reports First Quarter 2024 Financial ResultsPress release-2.06%-8.48%
Form 10-K MYOMO, INC. For: Dec 31SEC filing · Form 10-K-1.58%-9.89%
Form 10-Q MYOMO, INC. For: Sep 30SEC filing · Form 10-Q-1.99%+7.39%
Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and AuthorizationsPress release-1.99%+7.39%
That’s how MYO usually reacts to earnings — get an email when it moves on news →
Keep exploring

More MYO: analyst actions → · SEC filings → · MYO overview →

Other Healthcare names and their earnings

TickerEventsMedian 30-min% positive
Allogene Therapeutics, Inc. (ALLO)316+0.18%51%
Denali Therapeutics Inc. (DNLI)316+0.07%51%
ICU Medical, Inc. (ICUI)313+0.02%52%
XOMA Royalty Corporation (XOMA)3130.00%48%

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.